Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amphastar Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AMPH
Nasdaq
2834
https://amphastar.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth
- Apr 12th, 2024 2:26 pm
Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know
- Apr 4th, 2024 9:50 pm
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 1st, 2024 10:00 am
Is Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?
- Mar 27th, 2024 1:30 pm
Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
- Mar 26th, 2024 9:50 pm
Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know
- Mar 20th, 2024 9:50 pm
Brokers Suggest Investing in Amphastar (AMPH): Read This Before Placing a Bet
- Mar 11th, 2024 1:30 pm
Amphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Shares
- Mar 9th, 2024 4:31 am
Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares
- Mar 7th, 2024 4:29 am
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
- Mar 6th, 2024 9:05 pm
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript
- Mar 2nd, 2024 1:24 pm
Q4 2023 Amphastar Pharmaceuticals Inc Earnings Call
- Feb 29th, 2024 1:09 pm
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
- Feb 28th, 2024 10:25 pm
Amphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performance
- Feb 28th, 2024 10:12 pm
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
- Feb 28th, 2024 9:05 pm
Amphastar Pharmaceuticals (AMPH) Increases Yet Falls Behind Market: What Investors Need to Know
- Feb 22nd, 2024 10:45 pm
Wall Street Bulls Look Optimistic About Amphastar (AMPH): Should You Buy?
- Feb 22nd, 2024 2:30 pm
Amphastar (AMPH) to Report Q4 Earnings: What's in the Cards?
- Feb 21st, 2024 11:54 am
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
- Feb 20th, 2024 9:01 pm
It May Be Time To Revisit Amphastar Once It Settles After A Plunge
- Feb 16th, 2024 1:00 pm
Scroll